Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 2,712,778 | 2,578,860 | -133,918 | $32.09M | $26.02M | 8.31% | -$6.07M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 2,872,601 | 1,598,594 | -1,274,007 | $37.98M | $19.64M | 6.27% | -$18.34M |
| Scholar Rock Holding Corporation(SRRK) | 166,307 | 566,212 | +399,905 | $7.19M | $18.20M | 5.81% | +$11.02M |
| Arcellx Inc COMMON STOCK | 0 | 273,774 | +273,774 | $0 | $17.96M | 5.74% | +$17.96M |
| Merus N V | 614,812 | 346,756 | -268,056 | $25.85M | $14.59M | 4.66% | -$11.26M |
| Immunovant, Inc.(IMVT) | 1,118,508 | 853,472 | -265,036 | $27.71M | $14.59M | 4.66% | -$13.12M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 40,936 | +40,936 | $0 | $13.56M | 4.33% | +$13.56M |
| Nuvalent Inc | 145,234 | 190,401 | +45,167 | $11.37M | $13.50M | 4.31% | +$2.13M |
| Revolution Medicines, Inc.(RVMD) | 193,535 | 318,782 | +125,247 | $8.47M | $11.27M | 3.60% | +$2.81M |
| Janux Therapeutics, Inc.(JANX) | 145,876 | 342,062 | +196,186 | $7.81M | $9.24M | 2.95% | +$1.43M |
| Xenon Pharmaceuticals Inc.(XENE) | 375,845 | 274,633 | -101,212 | $14.73M | $9.21M | 2.94% | -$5.52M |
| Denali Therapeutics Inc.(DNLI) | 584,328 | 667,078 | +82,750 | $11.91M | $9.07M | 2.90% | -$2.84M |
| Centessa Pharmaceuticals PlcADS | 641,964 | 593,335 | -48,629 | $10.75M | $8.53M | 2.73% | -$2.22M |
| uniQure N.V.SHS(QURE) | 90,000 | 731,039 | +641,039 | $1.59M | $7.75M | 2.48% | +$6.16M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 208,437 | +208,437 | $0 | $7.21M | 2.30% | +$7.21M |
| CG Oncology, Inc.(CGON) | 0 | 289,823 | +289,823 | $0 | $7.10M | 2.27% | +$7.10M |
| Springworks Therapeutics Inc | 0 | 159,305 | +159,305 | $0 | $7.03M | 2.25% | +$7.03M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 500,966 | 440,073 | -60,893 | $6.98M | $6.88M | 2.20% | -$95.7K |
| Insmed Incorporated(INSM) | 106,610 | 87,059 | -19,551 | $7.36M | $6.64M | 2.12% | -$718.6K |
| Alkermes plcSHS(ALKS) | 416,968 | 192,352 | -224,616 | $11.99M | $6.35M | 2.03% | -$5.64M |
| Akero Therapeutics Inc | 0 | 156,185 | +156,185 | $0 | $6.32M | 2.02% | +$6.32M |
| Biohaven Ltd.(BHVN) | 186,413 | 250,564 | +64,151 | $6.96M | $6.02M | 1.92% | -$939.0K |
| Cytokinetics, Incorporated(CYTK) | 83,576 | 149,648 | +66,072 | $3.93M | $6.01M | 1.92% | +$2.08M |
| Blueprint Medicines Corp | 0 | 61,927 | +61,927 | $0 | $5.48M | 1.75% | +$5.48M |
| Vistagen Therapeutics, Inc.(VTGN) | 2,328,492 | 2,366,554 | +38,062 | $5.95M | $5.11M | 1.63% | -$835.1K |
| Protara Therapeutics, Inc.(TARA) | 332,394 | 1,190,579 | +858,185 | $1.76M | $5.07M | 1.62% | +$3.32M |
| Kalvista Pharmaceuticals Inc | 992,803 | 386,837 | -605,966 | $8.41M | $4.46M | 1.43% | -$3.94M |
| Edgewise Therapeutics, Inc.(EWTX) | 132,706 | 180,255 | +47,549 | $3.54M | $3.97M | 1.27% | +$422.4K |
| Surrozen, Inc.(SRZN) | 350,573 | 240,826 | -109,747 | $5.03M | $2.81M | 0.90% | -$2.22M |
| Protagonist Therapeutics Inc | 141,714 | 49,241 | -92,473 | $5.47M | $2.38M | 0.76% | -$3.09M |
| Enliven Therapeutics Inc | 96,716 | 120,430 | +23,714 | $2.18M | $2.37M | 0.76% | +$194.0K |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 21,052 | +21,052 | $0 | $2.33M | 0.74% | +$2.33M |
| Ascendis Pharma A/SADR(ASND) | 0 | 14,732 | +14,732 | $0 | $2.30M | 0.73% | +$2.30M |
| Helix Acquisition Corp IiCL A | 200,900 | 200,900 | 0 | $2.11M | $2.27M | 0.73% | +$160.7K |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 136,139 | +136,139 | $0 | $2.20M | 0.70% | +$2.20M |
| Amicus Therapeutics Inc COM | 0 | 268,919 | +268,919 | $0 | $2.19M | 0.70% | +$2.19M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 104,585 | +104,585 | $0 | $2.14M | 0.68% | +$2.14M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 208,016 | 33,816 | -174,200 | $11.64M | $1.79M | 0.57% | -$9.85M |
| Arbutus Biopharma Corporation(ABUS) | 0 | 467,882 | +467,882 | $0 | $1.63M | 0.52% | +$1.63M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 150,000 | 150,000 | 0 | $1.53M | $1.54M | 0.49% | +$18.0K |
| Geron Corporation(GERN) | 0 | 960,307 | +960,307 | $0 | $1.53M | 0.49% | +$1.53M |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 66,999 | +66,999 | $0 | $1.10M | 0.35% | +$1.10M |
| Zai Lab LimitedADR(ZLAB) | 0 | 26,421 | +26,421 | $0 | $954.9K | 0.30% | +$954.9K |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 124,523 | +124,523 | $0 | $912.8K | 0.29% | +$912.8K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 84,430 | +84,430 | $0 | $883.1K | 0.28% | +$883.1K |
| Soleno Therapeutics Inc | 0 | 11,155 | +11,155 | $0 | $797.0K | 0.25% | +$797.0K |
| InflaRx N.V.(IFRX) | 0 | 725,019 | +725,019 | $0 | $739.5K | 0.24% | +$739.5K |
| Solid Biosciences Inc | 0 | 198,150 | +198,150 | $0 | $733.2K | 0.23% | +$733.2K |
| Wave Life Sciences, Inc.SHS(WVE) | 721,209 | 89,833 | -631,376 | $8.92M | $725.9K | 0.23% | -$8.20M |
| MBX Biosciences, Inc.(MBX) | 0 | 96,615 | +96,615 | $0 | $713.0K | 0.23% | +$713.0K |
| Sionna Therapeutics, Inc.(SION) | 0 | 60,000 | +60,000 | $0 | $627.6K | 0.20% | +$627.6K |
| Bicara Therapeutics Inc | 0 | 47,078 | +47,078 | $0 | $613.4K | 0.20% | +$613.4K |
| 89bio Inc | 545,800 | 0 | -545,800 | $4.27M | $0 | — | -$4.27M |
| Acelyrin Inc | 1,704,825 | 0 | -1,704,825 | $5.35M | $0 | — | -$5.35M |
| Atyr Pharma Inc | 200,475 | 0 | -200,475 | $725.7K | $0 | — | -$725.7K |
| BioNTech SEADS(BNTX) | 61,403 | 0 | -61,403 | $7.00M | $0 | — | -$7.00M |
| Bristol-Myers Squibb Company(BMY) | 166,068 | 0 | -166,068 | $9.39M | $0 | — | -$9.39M |
| Cidara Therapeutics Inc | 47,642 | 0 | -47,642 | $1.28M | $0 | — | -$1.28M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 265,833 | 0 | -265,833 | $3.89M | $0 | — | -$3.89M |
| Crinetics Pharmaceuticals In | 317,060 | 0 | -317,060 | $16.21M | $0 | — | -$16.21M |
| EyePoint, Inc.(EYPT) | 579,500 | 0 | -579,500 | $4.32M | $0 | — | -$4.32M |
| Incyte Corporation(INCY) | 193,623 | 0 | -193,623 | $13.37M | $0 | — | -$13.37M |
| Iovance Biotherapeutics, Inc.(IOVA) | 949,401 | 0 | -949,401 | $7.03M | $0 | — | -$7.03M |
| Jasper Therapeutics, Inc.(JSPR) | 135,244 | 0 | -135,244 | $2.89M | $0 | — | -$2.89M |
| Mineralys Therapeutics, Inc.(MLYS) | 400,101 | 0 | -400,101 | $4.93M | $0 | — | -$4.93M |
| Neumora Therapeutics, Inc.(NMRA) | 428,137 | 0 | -428,137 | $4.54M | $0 | — | -$4.54M |
| Praxis Precision Medicines, Inc.(PRAX) | 134,178 | 0 | -134,178 | $10.33M | $0 | — | -$10.33M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 270,983 | 0 | -270,983 | $3.41M | $0 | — | -$3.41M |
| Tectonic Therapeutic, Inc.(TECX) | 9,434 | 0 | -9,434 | $435.6K | $0 | — | -$435.6K |
| Tourmaline Bio Inc | 126,400 | 0 | -126,400 | $2.56M | $0 | — | -$2.56M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 101,809 | 0 | -101,809 | $4.28M | $0 | — | -$4.28M |
| Verona Pharma PlcADS | 28,136 | 0 | -28,136 | $1.31M | $0 | — | -$1.31M |